Want to see CON full AI Analyst Report?
Top Page
Concentra Group Holdings Parent, Inc.
(NYSE:CON)
Select Model
Select Model
Rating:73Outperform
Price Target:
$38.00
▲(9.26% Upside)
Action:Reiterated
Date:09/08/26
The score is driven primarily by strong earnings-call execution and raised 2026 guidance, supported by solid revenue growth and improving cash generation. Offsetting these positives, the balance sheet remains the main risk due to elevated debt and a reduced equity cushion, while valuation is reasonable but not especially compelling given the low dividend yield.
Positive Factors
Revenue and Visit Growth
Revenue growth across total and core operations, combined with higher revenue per visit, indicates broad demand and pricing execution. This supports operating leverage and reinvestment, while the core increase reduces reliance on the acquired Pivot contribution over coming quarters.
Negative Factors
Elevated Leverage
High debt and a materially smaller equity cushion leave Concentra more sensitive to operating weakness, refinancing requirements and interest costs. Although recent leverage improved, the company still targets further reduction, so financial flexibility remains constrained.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and Visit Growth
Revenue growth across total and core operations, combined with higher revenue per visit, indicates broad demand and pricing execution. This supports operating leverage and reinvestment, while the core increase reduces reliance on the acquired Pivot contribution over coming quarters.
Read all positive factors
Concentra Group Holdings Parent, Inc. Key Performance Indicators (KPIs)
Concentra Group Holdings Parent, Inc. (CON) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$4.52B
Dividend Yield0.7%
Average Volume (3M)917.67K
Price to Earnings (P/E)22.9
Beta (1Y)0.64
Revenue Growth14.02%
EPS Growth31.92%
CountryUS
Employees9,983
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)1.55
Shares Outstanding127,517,740
10 Day Avg. Volume1,160,285
30 Day Avg. Volume917,668
Financial Highlights & Ratios
PEG Ratio2.05
Price to Book (P/B)6.34
Price to Sales (P/S)1.15
P/FCF Ratio12.65
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$41.00Price Target Upside17.88% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)1.65
Revenue Forecast (FY)$2.35B
Concentra Group Holdings Parent, Inc. Business Overview & Revenue Model
Company Description
Concentra Group Holdings Parent, Inc. is a U.S.-based provider of occupational health solutions. The company delivers a comprehensive suite of occupational and consumer health services, encompassing treatment for workers' compensation injuries, ur...
How the Company Makes Money
Concentra primarily makes money by delivering and administering occupational health services for employers and other payers across its clinic network and associated service channels. Key revenue streams generally include: (1) patient/encounter-bas...
Concentra Group Holdings Parent, Inc. Earnings Call Summary
Earnings Call Date:Aug 06, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Oct 29, 2026
Earnings Call Sentiment Positive
The call delivers a broadly positive message: robust top-line growth (10% revenue increase), notable margin expansion (EBITDA +22.5% and ~240 bps improvement), strong cash generation (operating cash flow and free cash flow roughly doubled YoY), successful acquisitions (Pivot/Nova ahead of underwriting), and updated, higher 2026 guidance. Manageable lowlights include comparability benefits from prior-year one-offs, expected moderation toward long-term visit growth, seasonality affecting margins, remaining debt/leveraging goals, and limited short-term contribution from new de novos. Overall, the strengths materially outweigh the risks and caveats discussed.Positive Updates
Revenue Growth
Total company revenue of $606.0M in Q2 2026, up 10.0% YoY; core revenue excluding Pivot was $589.1M, up 8.0% YoY.
Negative Updates
Comparability Noise from Prior-Year One-Time Items
Q2 2025 included ~ $4M of Nova acquisition-related integration costs and other one-time items; the removal of those costs provided a tailwind to 2026 comparables and margins, introducing some noise into YoY comparisons.
Read all updates
Q2-2026 Updates
Positive
Negative
Revenue Growth
Total company revenue of $606.0M in Q2 2026, up 10.0% YoY; core revenue excluding Pivot was $589.1M, up 8.0% YoY.
Read all positive updates
Company Guidance
Management raised 2026 guidance to revenue of $2.325–2.375 billion (low end +$50M), adjusted EBITDA of $485–495 million (low +$25M, high +$15M), and free cash flow of $220–240 million (both ends +$5M), with CapEx unchanged at $70–80 million. The upgrade follows a strong Q2: revenue $606.0M (+10% YoY; ex‑Pivot $589.1M, +8%), average visits >56,000/day (+2.6%), work‑comp visits +3.7%, employer‑services visits +1.8%, revenue per visit +4.6% (work comp +4.9%, employer services +3.2%), adjusted EBITDA $140.9M (+22.5% YoY) and margin 23.3% (+240 bps), adjusted net income $66.7M and adj. EPS $0.52 (~40% growth). Cash flow and balance‑sheet items noted: operating cash flow $135.2M, free cash flow $121M (vs $63.2M LY), investing cash use $14.2M, total debt $1.57B, cash $158M, net leverage just under 3x (from 3.4x) with a target near 2.5x, Term Loan B spread to step down 25 bps to 175 bps, ~$54M remaining repurchase capacity, and a $0.0625/share dividend payable Aug. 28.Concentra Group Holdings Parent, Inc. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
46
Neutral
Cash Flow
72
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.29B | 2.16B | 1.90B | 1.84B | 1.72B |
| Gross Profit | 670.56M | 613.09M | 527.98M | 512.43M | 408.19M |
| EBITDA | 459.77M | 408.93M | 368.26M | 360.15M | 330.20M |
| Net Income | 198.73M | 166.41M | 166.54M | 179.95M | 166.73M |
Balance Sheet | |||||
| Total Assets | 3.01B | 3.04B | 2.52B | 2.49B | 2.30B |
| Cash, Cash Equivalents and Short-Term Investments | 158.04M | 79.90M | 183.25M | 31.37M | 37.66M |
| Total Debt | 2.14B | 2.10B | 1.95B | 905.00M | 1.04B |
| Total Liabilities | 2.50B | 2.62B | 2.22B | 1.31B | 1.30B |
| Stockholders Equity | 477.10M | 393.28M | 275.67M | 1.16B | 973.32M |
Cash Flow | |||||
| Free Cash Flow | 349.75M | 197.06M | 210.35M | 164.98M | 228.35M |
| Operating Cash Flow | 335.55M | 279.40M | 274.68M | 234.32M | 274.34M |
| Investing Cash Flow | -69.64M | -414.86M | -71.27M | -75.31M | -57.75M |
| Financing Cash Flow | -181.74M | 32.10M | -51.53M | -165.29M | -209.86M |
Concentra Group Holdings Parent, Inc. Technical Analysis
Positive
34.78
Price Trends
33.38
Positive
29.97
Positive
25.77
Positive
Market Momentum
0.63
Negative
59.21
Neutral
72.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CON, the sentiment is Positive. The current price of 34.78 is above the 20-day moving average (MA) of 34.77, above the 50-day MA of 33.38, and above the 200-day MA of 25.77, indicating a bullish trend. The MACD of 0.63 indicates Negative momentum. The RSI at 59.21 is Neutral, neither overbought nor oversold. The STOCH value of 72.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CON.
Concentra Group Holdings Parent, Inc. Risk Analysis
Concentra Group Holdings Parent, Inc. disclosed 63 risk factors in its most recent earnings report. Concentra Group Holdings Parent, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Concentra Group Holdings Parent, Inc. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $4.52B | 22.88 | 47.30% | 0.70% | 14.02% | 31.92% | |
73 Outperform | $1.83B | 12.58 | 15.28% | 2.37% | ― | ― | |
69 Neutral | $26.01B | 26.35 | 11.57% | 0.90% | 6.41% | 33.31% | |
66 Neutral | $3.75B | 39.58 | 4.10% | ― | 11.89% | 85.76% | |
62 Neutral | $1.15B | -13.03 | -26.30% | ― | 52.54% | 2.69% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
39 Underperform | $88.99M | -5.60 | -107.61% | ― | 92.59% | 0.97% |
* General Sector Average
CON
Concentra Group Holdings Parent, Inc.
35.47
14.81
71.68%
LH
Labcorp Holdings
320.71
44.60
16.15%
NVST
Envista Holdings
23.35
2.46
11.78%
SPAI
Safe Pro Group, Inc.
4.37
-2.77
-38.80%
FLOC
Flowco Holdings Inc Class A
20.25
5.28
35.23%
BBNX
Beta Bionics, Inc.
21.89
-1.01
-4.41%
Concentra Group Holdings Parent, Inc. Corporate Events
Business Operations and StrategyExecutive/Board Changes
Concentra Announces CFO Appointment Amid Leadership Succession
Positive
Sep 8, 2026
Concentra announced on September 8, 2026, that Tanner Newton, currently senior vice president of strategy and finance, will become executive vice president and chief financial officer effective November 1, 2026. He will report to Matt DiCanio, who...
Stock BuybackRegulatory Filings and Compliance
Concentra Announces Insider Share Repurchase Agreement Completion
Positive
Aug 27, 2026
On August 21, 2026, Concentra Group Holdings Parent, Inc. agreed to repurchase 1,000,000 shares of its common stock from chairman Robert A. Ortenzio and related entities in a privately negotiated transaction at $34.65 per share, a 1% discount to t...
Business Operations and StrategyExecutive/Board ChangesStock BuybackDividendsFinancial Disclosures
Concentra Raises 2026 Guidance After Strong Q2 Results
Positive
Aug 6, 2026
Concentra reported strong second-quarter 2026 results on August 6, 2026, with revenue up 10.0% to $606.0 million and net income rising 45.7% to $67.3 million. Adjusted EBITDA grew 22.5% to $140.9 million, supported by higher revenue per visit, inc...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.